Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Nash Phase 3 Trial

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on May 02, 2022 9:07am

89 Views

Post# 34647018

RE:RE:Nash Phase 3 Trial

I am also a Christian and I am not only for resurrections in Nash but also for miracles in Oncology......However as you know God helps those who help themselves ...That's why I keep pushing for better execution in the commercial activities.... I really like the renewed focus on Hiv related ilnesses as demonstrated by the last job posted ....
Unfortunately the organisation being built by Paul mostly from scratch has gone un noticed so far but the renewed THTX is taking shape .... Someday we will see the Light and that day is not far away...

SPCEO1 wrote: As a Christian, I am all for resurrections! Let's hope we can get one with the NASH phase III trial but it will be a bonus if it happens as far as I am concerned.

palinc2000 wrote: https://youtu.be/krjQYwWi7ZU